Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand

  • Crichton, S.
  • Belfrage, E.
  • Collins, I.J.
  • Doerholt, K.
  • Judd, A.
  • Le Coeur, S.
  • Spoulou, V.
  • Goodall, R.
  • Scherpbier, H.
  • Smit, C.
  • Goetghebuer, T.
  • Gibb, D.M.
  • Noguera, A.
  • Navarro, M.L.
  • Ramos, J.T.
  • Galli, L.
  • Giaquinto, C.
  • Thorne, C.
  • Santa Ansone.
  • Marczynska, M.
  • Okhonskaia, L.
  • de Tejada, BM.
  • Jourdain, G.
  • Decker, L.
  • Ene, L.
  • Hainaut, M.
  • Van der Kelen, E.
  • Delforge, M.
  • de Martino, M.
  • Tovo, PA.
  • Patrizia, O.
  • Larovere, D.
  • Ruggeri, M.
  • Faldella, G.
  • Baldi, F.
  • Badolato, R.
  • Montagnani, C.
  • Venturini, E.
  • Lisi, C.
  • Di Biagio, A.
  • Taramasso, L.
  • Giacomet, V.
  • Erba, P.
  • Esposito, S.
  • Lipreri, R.
  • Salvini, F.
  • Tagliabue, C.
  • Cellini, M.
  • Bruzzese, E.
  • Lo Vecchio, A.
  • Rampon, O.
  • Dona, D.
  • Romano, A.
  • Dodi, I.
  • Maccabruni, A.
  • Consolini, R.
  • Bernardi, S.
  • Kuekou, HT.
  • Genovese, O.
  • Olmeo, P.
  • Cristiano, L.
  • Mazza, A.
  • Gabiano, C.
  • Garazzino, S.
  • Pellegatta, A.
  • Pajkrt, D.
  • Scherpbier, HJ.
  • Weijsenfeld, AM.
  • de Boer, CG.
  • Jurriaans, S.
  • Back, NKT.
  • Zaaijer, HL.
  • Berkhout, B.
  • Cornelissen, MTE.
  • Schinkel, CJ.
  • Wolthers, KC.
  • Fraaij, PLA.
  • van Rossum, AMC.
  • Vermont, CL.
  • van der Knaap, LC.
  • Visser, EG.
  • Boucher, CAB.
  • Koopmans, MPG.
  • van Kampen, JJA.
  • Pas, SD.
  • Henriet, SSV.
  • van de Flier, M.
  • van Aerde, K.
  • Strik-Albers, R.
  • Rahamat-Langendoen, J.
  • Stelma, FF.
  • Scholvinck, EH.
  • de Groot-de Jonge, H.
  • Niesters, HGM.
  • van Leer-Buter, CC.
  • Knoester, M.
  • Bont, LJ.
  • Geelen, SPM.
  • Wolfs, TFW.
  • Nauta, N.
  • Schuurman, R.
  • Verduyn-Lunel, F.
  • Wensing, AMJ.
  • Reiss, P.
  • Zaheri, S.
  • Bezemer, DO.
  • van Sighem, AI.
  • Smit, C.
  • Wit, FWMN.
  • Hillebregt, M.
  • de Jong, A.
  • Woudstra, T.
  • Bergsma, D.
  • Grivell, S.
  • Meijering, R.
  • Raethke, M.
  • Rutkens, T.
  • de Groot, L.
  • van den Akker, M.
  • Bakker, Y.
  • Bezemer, M.
  • El Berkaoui, A.
  • Geerlinks, J.
  • Koops, J.
  • Kruijne, E.
  • Lodewijk, C.
  • Lucas, E.
  • van der Meer, R.
  • Munjishvili, L.
  • Paling, E.
  • Peeck, B.
  • Ree, C.
  • Regtop, R.
  • Ruijs, Y.
  • van de Sande, L.
  • Schoorl, M.
  • Schnorr, P.
  • Tuijn, E.
  • Veenenberg, L.
  • van der Vliet, S.
  • Wisse, A.
  • Witte, EC.
  • Tuk, B.
  • Popielska, J.
  • Pokorska-Spiewak, M.
  • Oldakowska, A.
  • Zawadka, K.
  • Coupland, U.
  • Doroba, M.
  • Voronin, E.
  • Miloenko, M.
  • Labutina, S.
  • Soler-Palacin, P.
  • Frick, MA.
  • Perez-Hoyos, S.
  • Mur, A.
  • Lopez, N.
  • Mendez, M.
  • Mayol, L.
  • Vallmanya, T.
  • Calavia, O.
  • Garcia, L.
  • Coll, M.
  • Pineda, V.
  • Rius, N.
  • Rovira, N.
  • Duenas, J.
  • Gamell, A.
  • Fortuny, C.
  • Noguera-Julian, A.
  • Mellado, MJ.
  • Escosa, L.
  • Hortelano, MG.
  • Sainz, T.
  • Gonzalez-Tome, MI.
  • Rojo, P.
  • Blazquez, D.
  • Prieto, L.
  • Guillen, S.
  • Saavedra, J.
  • Santos, M.
  • Munoz, MA.
  • Ruiz, B.
  • Mc Phee, CF.
  • de Ory, SJ.
  • Alvarez, S.
  • Roa, MA.
  • Beceiro, J.
  • Martinez, J.
  • Badillo, K.
  • Apilanez, M.
  • Pocheville, I.
  • Garrote, E.
  • Colino, E.
  • Sirvent, JG.
  • Garzon, M.
  • Roman, V.
  • Montesdeoca, A.
  • Mateo, M.
  • Munoz, MJ.
  • Angulo, R.
  • Neth, O.
  • Falcon, L.
  • Terol, P.
  • Santos, JL.
  • Moreno, D.
  • Lendinez, F.
  • Grande, A.
  • Romero, FJ.
  • Perez, C.
  • Lillo, M.
  • Losada, B.
  • Herranz, M.
  • Bustillo, M.
  • Guerrero, C.
  • Collado, P.
  • Couceiro, JA.
  • Perez, A.
Objective: The aim of this study was to describe growth during puberty in young people with vertically acquired HIV. Design: Pooled data from 12 paediatric HIV cohorts in Europe and Thailand. Methods: One thousand and ninety-four children initiating a nonnucleoside reverse transcriptase inhibitor or boosted protease inhibitor based regimen aged 1-10 years were included. Super Imposition by Translation And Rotation (SITAR) models described growth from age 8 years using three parameters (average height, timing and shape of the growth spurt), dependent on age and height-for-age z-score (HAZ) (WHO references) at antiretroviral therapy (ART) initiation. Multivariate regression explored characteristics associated with these three parameters. Results: At ART initiation, median age and HAZ was 6.4 [interquartile range (IQR): 2.8, 9.0] years and -1.2 (IQR: -2.3 to -0.2), respectively. Median follow-up was 9.1 (IQR: 6.9, 11.4) years. In girls, older age and lower HAZ at ART initiation were independently associated with a growth spurt which occurred 0.41 (95% confidence interval 0.20-0.62) years later in children starting ART age 6 to 10 years compared with 1 to 2 years and 1.50 (1.21-1.78) years later in those starting with HAZ less than -3 compared with HAZ at least -1. Later growth spurts in girls resulted in continued height growth into later adolescence. In boys starting ART with HAZ less than -1, growth spurts were later in children starting ART in the oldest age group, but for HAZ at least -1, there was no association with age. Girls and boys who initiated ART with HAZ at least -1 maintained a similar height to the WHO reference mean. Conclusion: Stunting at ART initiation was associated with later growth spurts in girls. Children with HAZ at least -1 at ART initiation grew in height at the level expected in HIV negative children of a comparable age.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

  • Jiménez de Ory, Santiago
  • Ramos, José Tomas
  • Fortuny, Clàudia
  • González-Tomé, María Isabel
  • Mellado, Maria José
  • Moreno, David
  • Frick, Marie Antoinette
Retrospective study; Spanish Paediatric HIV Network; Rates of perinatal HIV, Estudio retrospectivo; Red Española de VIH Pediátrico; Tasas de VIH perinatal, Estudi retrospectiu; Xarxa espanyola de VIH Pediàtrica; Taxes de VIH perinatal, Background: There are not enough nationwide studies on perinatal HIV transmission in connection with a combination of antiretroviral treatments in Spain. Our objectives were to study sociodemographic changes and trends in the rates of HIV diagnoses and perinatal transmission in Spain from 1997 to 2015. Methods: A retrospective study using data from Spanish Paediatric HIV Network (CoRISpe) and Spanish Minimum Basic Data Set (MDBS) was performed. HIV- diagnosed children between 1997 and 2015 were selected. Sociodemographic, clinical and immunovirological data of HIV-infected children and their mothers were studied in four calendar periods (P1: 1997-2000; P2: 2001-2005; P3: 2006-2010; P4: 2011-2015). Rates of perinatal HIV diagnoses and transmission from 1997 to 2015 were calculated. Results: A total of 532 HIV-infected children were included in this study. Of these children, 406 were Spanish (76.3%) and 126 immigrants (23.7%). A decrease in the number of HIV diagnoses, 203 (38.2%) children in the first (P1), 149 (28%) in the second (P2), 130 (24.4%) in the third (P3) and 50 (9.4%) in the fourth (P4) calendar periods was studied. The same decrease in the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and P4, 19 (5.1%)) was monitored. However, an increase in the number of HIV diagnoses by sexual contact (P1: 0%; P2: 1.3%; P3: 4.6%; P4: 16%) was observed. The rates of new perinatal HIV diagnoses and perinatal transmission in Spanish children decreased from 0.167 to 0.005 per 100,000 inhabitants and 11.4% to 0.4% between 1997 and 2015, respectively. Conclusions: A decline of perinatal HIV diagnoses and transmission was observed. However, an increase of teen-agers HIV diagnoses with sexual infection was studied. Public awareness campaigns directed to teen-agers are advisable to prevent HIV infection by sexual contact., This work has been partially funded by Red Temática de Investigación en SIDA (RED RIS) supported by Instituto de Salud Carlos III (ISCIII) (RD12/0017/0035, RD12/0017/0037 and RD16/0025/0019), project as part of the Plan R+D+I (2008-2011; 2013-2016) and cofinanced by ISCIII Subdirección General de Evaluación and Fondo Europeo de Desarrollo Regional (FEDER), RISEPICLIN-19/2015, Fondo para la Investigación Sanitaria of the Spanish Ministry of Science and Innovation (FIS PI13/00422, PI16/01863), CYTED (214RT0482) and EPIICAL Project. CIBER-BBN is an initiative funded by the VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, the Consolider Program, and CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. COST CA17140 Cancer Nanomedicine-Front The Bench to Bebside. We thank the Spanish HIV HGM BioBank supported by ISC III project RETIC PT13/0010/0028 and PT17/0015/0042. No funding for this work was received from National Institutes of Health (NIH), Wellcome Trust and Howard Hughes Medical Institute (HHMI)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients

  • Falcon-Neyra, Lola
  • Palladino, Claudia
  • Navarro, Maria Luisa
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • González-Tomé, María Isabel
  • De Ory, Santiago J.
  • Frick, Marie Antoinette|||0000-0002-2553-5090
  • Fortuny Guasch, Claudia
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Bermúdez Moreno, Elena
  • Santos, Juan Luis
  • Olbrich, Peter
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Briz, Verónica|||0000-0003-2297-5098
  • Neth, Olaf|||0000-0001-5018-0466
To assess the safety and efficacy of rilpivirine in combination with emtricitabine and tenofovir (RPV/FTC/TDF) as a once-daily single-tablet regimen (STR) in HIV-1-infected children and adolescents we performed a multicenter case series study of HIV-1-infected patients. Inclusion criteria were initiation of therapy with RPV/FTC/TDF before the age of 18. Patients were divided into undetectable viral load (uVL) group, HIV-1 RNA < 20 copies/mL on stable combined antiretroviral therapy (cART), and detectable viral load (dVL) group, HIV-1 RNA ≥ 20 copies/mL at RPV/FTC/TDF initiation. Patients were monitored from the date of RPV/FTC/TDF initiation until June 30, 2015, RPV/FTC/TDF discontinuation or failure to follow-up. Seventeen patients (8 in uVL and 9 in dVL group) with age between 11.6 and 17.6 were included. Reasons for switching were toxicity (n = 4) and simplification (n = 4) in uVL; viral failure (n = 8) and cART initiation (n = 1) in the dVL group. After a median follow-up of 90 (uVL) and 40 weeks (dVL), 7/8 (86%) patients maintained and 8/9 (89%) achieved and maintained HIV-1 suppression. Median CD4 count increased from 542 to 780/μL (uVL, P = 0.069) and 480 to 830/μL (dVL, P = 0.051). Five patients (2 in uVL and 3 in dVL) improved their immunological status from moderate to no immunosuppression. Serum lipid profiles improved in both groups; cholesterol dropped significantly in the dVL group (P = 0.008). Grade 1 laboratory adverse events (AEs) were observed in 3 patients. No clinical AEs occurred. Adherence was complete in 9 patients (5 in uVL and 4 in dVL); 1 adolescent interrupted treatment. Once-daily STR with RPV/FTC/TDF may be a safe and effective choice in selected HIV-1-infected adolescents and children.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

  • Jiménez De Ory, S.
  • Ramos Amador, José Tomás
  • Fortuny Guasch, Claudia
  • González-Tomé, María Isabel
  • Mellado Peña, María José|||0000-0003-2251-9666
  • Moreno Pérez, David|||0000-0002-7017-4095
  • Gavilán, C.
  • Menasalvas, A. I.
  • Piqueras, Ana Isabel
  • Frick, Marie Antoinette|||0000-0002-2553-5090
  • Muñoz-Fernández, M. A.
  • Navarro, Maria Luisa
Background There are not enough nationwide studies on perinatal HIV transmission in connection with a combination of antiretroviral treatments in Spain. Our objectives were to study sociodemographic changes and trends in the rates of HIV diagnoses and perinatal transmission in Spain from 1997 to 2015. Methods A retrospective study using data from Spanish Paediatric HIV Network (CoRISpe) and Spanish Minimum Basic Data Set (MDBS) was performed. HIV- diagnosed children between 1997 and 2015 were selected. Sociodemographic, clinical and immunovirological data of HIV-infected children and their mothers were studied in four calendar periods (P1: 1997-2000; P2: 2001-2005; P3: 2006-2010; P4: 2011-2015). Rates of perinatal HIV diagnoses and transmission from 1997 to 2015 were calculated. Results A total of 532 HIV-infected children were included in this study. Of these children, 406 were Spanish (76.3%) and 126 immigrants (23.7%). A decrease in the number of HIV diagnoses, 203 (38.2%) children in the first (P1), 149 (28%) in the second (P2), 130 (24.4%) in the third (P3) and 50 (9.4%) in the fourth (P4) calendar periods was studied. The same decrease in the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and P4, 19 (5.1%)) was monitored. However, an increase in the number of HIV diagnoses by sexual contact (P1: 0%; P2: 1.3%; P3: 4.6%; P4: 16%) was observed. The rates of new perinatal HIV diagnoses and perinatal transmission in Spanish children decreased from 0.167 to 0.005 per 100,000 inhabitants and 11.4% to 0.4% between 1997 and 2015, respectively. Conclusions A decline of perinatal HIV diagnoses and transmission was observed. However, an increase of teen-agers HIV diagnoses with sexual infection was studied. Public awareness campaigns directed to teen-agers are advisable to prevent HIV infection by sexual contact.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

  • Jiménez de Ory, Santiago
  • Ramos, José Tomas
  • Fortuny, Clàudia
  • González-Tomé, María Isabel
  • Mellado, Maria José
  • Moreno, David
  • Frick, Marie Antoinette
Retrospective study; Spanish Paediatric HIV Network; Rates of perinatal HIV, Estudio retrospectivo; Red Española de VIH Pediátrico; Tasas de VIH perinatal, Estudi retrospectiu; Xarxa espanyola de VIH Pediàtrica; Taxes de VIH perinatal, Background: There are not enough nationwide studies on perinatal HIV transmission in connection with a combination of antiretroviral treatments in Spain. Our objectives were to study sociodemographic changes and trends in the rates of HIV diagnoses and perinatal transmission in Spain from 1997 to 2015. Methods: A retrospective study using data from Spanish Paediatric HIV Network (CoRISpe) and Spanish Minimum Basic Data Set (MDBS) was performed. HIV- diagnosed children between 1997 and 2015 were selected. Sociodemographic, clinical and immunovirological data of HIV-infected children and their mothers were studied in four calendar periods (P1: 1997-2000; P2: 2001-2005; P3: 2006-2010; P4: 2011-2015). Rates of perinatal HIV diagnoses and transmission from 1997 to 2015 were calculated. Results: A total of 532 HIV-infected children were included in this study. Of these children, 406 were Spanish (76.3%) and 126 immigrants (23.7%). A decrease in the number of HIV diagnoses, 203 (38.2%) children in the first (P1), 149 (28%) in the second (P2), 130 (24.4%) in the third (P3) and 50 (9.4%) in the fourth (P4) calendar periods was studied. The same decrease in the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and P4, 19 (5.1%)) was monitored. However, an increase in the number of HIV diagnoses by sexual contact (P1: 0%; P2: 1.3%; P3: 4.6%; P4: 16%) was observed. The rates of new perinatal HIV diagnoses and perinatal transmission in Spanish children decreased from 0.167 to 0.005 per 100,000 inhabitants and 11.4% to 0.4% between 1997 and 2015, respectively. Conclusions: A decline of perinatal HIV diagnoses and transmission was observed. However, an increase of teen-agers HIV diagnoses with sexual infection was studied. Public awareness campaigns directed to teen-agers are advisable to prevent HIV infection by sexual contact., This work has been partially funded by Red Temática de Investigación en SIDA (RED RIS) supported by Instituto de Salud Carlos III (ISCIII) (RD12/0017/0035, RD12/0017/0037 and RD16/0025/0019), project as part of the Plan R+D+I (2008-2011; 2013-2016) and cofinanced by ISCIII Subdirección General de Evaluación and Fondo Europeo de Desarrollo Regional (FEDER), RISEPICLIN-19/2015, Fondo para la Investigación Sanitaria of the Spanish Ministry of Science and Innovation (FIS PI13/00422, PI16/01863), CYTED (214RT0482) and EPIICAL Project. CIBER-BBN is an initiative funded by the VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, the Consolider Program, and CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. COST CA17140 Cancer Nanomedicine-Front The Bench to Bebside. We thank the Spanish HIV HGM BioBank supported by ISC III project RETIC PT13/0010/0028 and PT17/0015/0042. No funding for this work was received from National Institutes of Health (NIH), Wellcome Trust and Howard Hughes Medical Institute (HHMI)